Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

43
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
43
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

21
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

199
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
199
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

27
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

295
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right-Left Differential Cyanosis in a Newborn With a Circumflex Retroesophageal Left Aortic Arch.

JACC. Case reports·2026
Same author

Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARC.

The Lancet. Child & adolescent health·2024
Same author

Successful pharmaco-invasive approach using a lower alteplase dose and VA-ECMO support in high-risk pulmonary embolism: case report.

Frontiers in cardiovascular medicine·2024
Same author

Accessory mitral valve tissue: a differential diagnosis of an obstructive mass on the left ventricular outflow tract.

Cardiology in the young·2023
Same author

Use of hepatic support with MARS in a patient with SARS-CoV-2 Pneumonia, in treatment with ECMO and CRRT therapies: Case Report.

The journal of extra-corporeal technology·2023
Same author

Neurogenic diabetes insipidus in a critical patient with COVID-19 pneumonia in treatment with extracorporeal membrane oxygenation: a case report.

The journal of extra-corporeal technology·2023
Same journal

Pulmonary artery sling repair via left thoracotomy.

Cardiology in the young·2026
Same journal

Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?

Cardiology in the young·2026
Same journal

Emotional intelligence: An added metric of neurodevelopment in a CHD cohort.

Cardiology in the young·2026
Same journal

Case-based learning in paediatric cardiology training.

Cardiology in the young·2026
Same journal

A scoping review of the evidence supporting antiarrhythmic use after paediatric cardiac surgery.

Cardiology in the young·2026
Same journal

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

Cardiology in the young·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
06:15

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents

Published on: July 10, 2017

13.0K

Critical CHD screening programme: a 3-year multicentre experience in Mexico.

René Gómez-Gutiérrez1,2, José M Galindo-Hayashi3, Consuelo Cantú-Reyna1,3

  • 1Genomi-k, Monterrey, Nuevo León, 64060, Mexico.

Cardiology in the Young
|July 8, 2022
PubMed
Summary
This summary is machine-generated.

Pulse oximetry screening for critical congenital heart defects (CHDs) in Mexico showed a low prevalence of 6.69:10,000 newborns. A systematic screening process improved result interpretation and follow-up, despite algorithm choice not significantly impacting false-positive rates.

Keywords:
Newborncongenitaldata managementfalse-positive rateheart defectsmass screening

More Related Videos

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

8.1K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K

Related Experiment Videos

Last Updated: Sep 5, 2025

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
06:15

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents

Published on: July 10, 2017

13.0K
Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

8.1K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.7K

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Public Health Screening

Background:

  • Congenital heart defects (CHDs) are common birth defects, with critical CHDs affecting 1 in 4 newborns with heart defects.
  • Mexico lacks comprehensive data on CHD prevalence, highlighting the need for effective screening programs.
  • Pulse oximetry screening is a global standard, yet challenges in algorithm interpretation and data management persist.

Purpose of the Study:

  • To report preliminary findings from a 3-year, multicenter pulse oximetry screening program in Mexico.
  • To evaluate the impact of different screening algorithms on false-positive rates.
  • To address critical challenges in implementing CHD screening programs.

Main Methods:

  • A retrospective study analyzed data from 8960 newborns screened between February 2016 and July 2019 across five hospitals.
  • Two algorithms, New Jersey and American Academy of Pediatrics, were consecutively implemented.
  • The false-positive rate was calculated to assess algorithm effectiveness.

Main Results:

  • The estimated prevalence of critical CHD was 6.69 per 10,000 newborns.
  • The American Academy of Pediatrics algorithm yielded a lower false-positive rate (0.71%) compared to the New Jersey algorithm (1%).
  • Algorithm choice did not significantly correlate with a reduction in the observable false-positive rate.

Conclusions:

  • While algorithm choice may not be the primary driver of false-positive reduction, a systematic screening process enhances result confidence and newborn follow-up.
  • Further investigation into other factors influencing false-positive rates is warranted.
  • The study provides valuable preliminary data on critical CHD prevalence and screening program implementation in Mexico.